What's new

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised

Apr 22, 2025 - 13:18
 0
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Bath & Body Works has a major tariff advantage. Here's what that means for shoppers

Next Article

Hard Rock Hotel London, Ontario, Officially Opens Its Doors

Related Posts

Human medicines European public assessment report (EPAR): Revestive, teduglutide, Date of authorisation: 30/08/2012, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

EMEA-002762-PIP02-20-M02

EMEA-002762-PIP02-20-M02

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Rekambys, rilpivirine, Date of authorisation: 17/12/2020, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 12, 2025  0